Shanghai Labway Clinical Laboratory Co Ltd Cash Flow Conversion Efficiency
Shanghai Labway Clinical Laboratory Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million ≈ $19.87 Million USD) by net assets (CN¥1.67 Billion ≈ $244.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 301060 share price today for real-time trading data and today's change.
Shanghai Labway Clinical Laboratory Co Ltd Cash Flow Conversion Ratio Explained
Shanghai Labway Clinical Laboratory Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency. Also see Shanghai Labway Clinical Laboratory Co L (301060) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Tieke Shougang Railway Tech Co Ltd
SHG:688569
|
0.065x |
|
Aeon Credit Service Bhd
KLSE:5139
|
-0.076x |
|
IOL Chemicals and Pharmaceuticals Limited
NSE:IOLCP
|
0.006x |
|
Shandong Ruifeng Chemical Co Ltd
SHE:300243
|
-0.005x |
|
Hainan Expressway Co Ltd
SHE:000886
|
-0.027x |
|
Shenzhen Sea Star Technology
SHE:002137
|
0.031x |
|
Haier Smart Home Co Ltd
XETRA:690D
|
0.049x |
|
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
|
0.027x |
Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. Review how much free cash does Shanghai Labway Clinical Laboratory Co L generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.64 Billion ≈ $240.69 Million |
CN¥268.85 Million ≈ $39.34 Million |
0.163x | +37.55% |
| 2024-12-31 | CN¥1.82 Billion ≈ $266.37 Million |
CN¥216.31 Million ≈ $31.65 Million |
0.119x | -56.98% |
| 2023-12-31 | CN¥1.98 Billion ≈ $289.76 Million |
CN¥546.99 Million ≈ $80.04 Million |
0.276x | +645.91% |
| 2022-12-31 | CN¥2.27 Billion ≈ $332.58 Million |
CN¥84.17 Million ≈ $12.32 Million |
0.037x | -72.83% |
| 2021-12-31 | CN¥1.64 Billion ≈ $239.96 Million |
CN¥223.51 Million ≈ $32.71 Million |
0.136x | +1.28% |
| 2020-12-31 | CN¥1.25 Billion ≈ $182.53 Million |
CN¥167.87 Million ≈ $24.57 Million |
0.135x | +131.24% |
| 2019-12-31 | CN¥1.21 Billion ≈ $177.52 Million |
CN¥70.60 Million ≈ $10.33 Million |
0.058x | -62.80% |
| 2018-12-31 | CN¥1.18 Billion ≈ $172.83 Million |
CN¥184.79 Million ≈ $27.04 Million |
0.156x | +280.90% |
| 2017-12-31 | CN¥1.10 Billion ≈ $161.60 Million |
CN¥-95.52 Million ≈ $-13.98 Million |
-0.086x | -295.93% |
| 2016-12-31 | CN¥614.70 Million ≈ $89.95 Million |
CN¥27.14 Million ≈ $3.97 Million |
0.044x | -83.09% |
| 2015-12-31 | CN¥305.25 Million ≈ $44.67 Million |
CN¥79.70 Million ≈ $11.66 Million |
0.261x | +163.44% |
| 2014-12-31 | CN¥201.13 Million ≈ $29.43 Million |
CN¥-82.77 Million ≈ $-12.11 Million |
-0.412x | -3402.03% |
| 2013-12-31 | CN¥130.79 Million ≈ $19.14 Million |
CN¥1.63 Million ≈ $238.52K |
0.012x | -- |
About Shanghai Labway Clinical Laboratory Co Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing… Read more